Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous mesenchymal stem cell-derived neural progenitors (1 trial)
Parkinson Disease (Phase 1)
Trials (1 total)
Trial APIs (1 total)